Sub-Total: $0.00
Specialty
Showing 33–48 of 61 results
-
Emerging Strategies in the Management of Chronic Fibrosing ILD Patients Who Have Contracted COVID-19
Read more -
New Paradigms in the Biological Therapies for Atopic Dermatitis
Read more -
New Paradigms in the Prevention and Treatment of Migraine with HT1F Agonist and mAb Against CGRP Pathway or its Receptor
Read more -
New Horizons in Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes with SGLT-2, GLP-1 RAs and DPP-4 Based Therapies
Read more -
Changing Landscape of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Outcomes in Individuals with Diabetes
Read more -
Changing Landscape of Treatment Options for Migraine with Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) Pathway or its Receptor
Read more -
Emerging Newer Therapies in the Management of Lung Function, Exacerbations, Safety and Tolerability in Patients with COPD
Read more -
Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Read more -
Emerging Strategies in the Diagnosis and Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Read more -
New Era in the Lipid Lowering Treatment with PCSK9 Inhibitors (Evolocumab and Alirocumab) in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia
Read more -
Emerging Strategies in the Diagnosis and Treatment of Interstitial Lung Disease (ILD)
Read more -
Emerging Strategies in the Anti–Interleukin-5 Monoclonal Antibody Based Targeted Therapies for Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Read more -
Efficacy and Safety of Fixed-ratio Combination of Insulin Degludec and Liraglutide (IDegLira) and Insulin Glargine and Lixisenatide (IGlarLixi) in Patients with Type 2 Diabetes
Read more -
Emerging Strategies in the Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) or its Receptor in the Preventive Treatment of Migraine
Read more -
Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab)
Read more -
Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Read more
